Skip to main content
Kent Academic Repository

Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?

Papanastasiou, Evangelos, Shergill, Sukhwinder S. (2021) Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)? Journal of Psychopharmacology, 35 (9). pp. 1158-1160. ISSN 0269-8811. (doi:10.1177/02698811211000773) (KAR id:96366)

Item Type: Article
DOI/Identification number: 10.1177/02698811211000773
Subjects: R Medicine
Divisions: Divisions > Division of Natural Sciences > Kent and Medway Medical School
Funders: European Research Council (https://ror.org/0472cxd90)
Depositing User: Rachael Heller
Date Deposited: 27 Sep 2022 15:07 UTC
Last Modified: 28 Sep 2022 12:32 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/96366 (The current URI for this page, for reference purposes)

University of Kent Author Information

Shergill, Sukhwinder S..

Creator's ORCID: https://orcid.org/0000-0003-4928-9100
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.